InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

- Current share price for DXB : $0.215

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$129 DMX-200 Phase 2a Data Presentation 16 Aug 2017 8:25AM $0.010 $0.215 risen by 2,050%
$129 Board Restructure and Incentive Package for CEO 1 Aug 2017 8:20AM $0.012 $0.215 risen by 1,691.67%
$129 Appendix 4C - quarterly 31 Jul 2017 8:17AM $0.011 $0.215 risen by 1,854.55%
$129 Phase 2a Trial Result Release Interview Video Recording 17 Jul 2017 8:21AM $0.015 $0.215 risen by 1,333.33%
$129 Phase 2a Trial Result Release Conference Call Recording 13 Jul 2017 6:23PM $0.011 $0.215 risen by 1,854.55%
$129 DMX-200 Phase 2a Trial - Investor Presentation 12 Jul 2017 9:50AM $0.011 $0.215 risen by 1,854.55%
$129 Positive Results from Phase 2a Trial of DMX-200 12 Jul 2017 9:50AM $0.011 $0.215 risen by 1,854.55%
$129 Trading Halt 11 Jul 2017 9:12AM $0.011 $0.215 risen by 1,854.55%
$129 Change of director interest notices x 3 6 Jul 2017 7:22PM $0.011 $0.215 risen by 1,854.55%
$129 Appendix 3B 3 Jul 2017 8:24AM $0.010 $0.215 risen by 2,050%
$129 Gold Coast Investment Showcase Presentation 22 Jun 2017 9:13AM $0.010 $0.215 risen by 2,050%
$129 CEO Interview 14 Jun 2017 1:59PM $0.008 $0.215 risen by 2,587.50%
$129 Research Validates Relevance of DMX Receptor-HIT Technology 13 Jun 2017 9:34AM $0.008 $0.215 risen by 2,587.50%
$129 Dimerix Hosts US Key Opinion Leader Meeting 6 Jun 2017 8:26AM $0.007 $0.215 risen by 2,971.43%
$129 Shareholder Briefing 16 May 2017 8:25AM $0.007 $0.215 risen by 2,971.43%
$129 Initial Director's Interest Notice 1 May 2017 8:14AM $0.007 $0.215 risen by 2,971.43%
$129 Director Appointment 1 May 2017 8:13AM $0.007 $0.215 risen by 2,971.43%
$129 Appendix 4C - quarterly 28 Apr 2017 8:13AM $0.007 $0.215 risen by 2,971.43%
$129 Investor Update 11 Apr 2017 8:27AM $0.007 $0.215 risen by 2,971.43%
$129 Shareholder Newsletter 4 Apr 2017 1:37PM $0.006 $0.215 risen by 3,483.33%
$129 Research Report and Pro-active Investor Presentation 28 Mar 2017 9:18AM $0.006 $0.215 risen by 3,483.33%
$129 Appendix 3B 24 Mar 2017 8:25AM $0.006 $0.215 risen by 3,483.33%
$129 Receipt of $420k Research & Development Tax Refund 21 Mar 2017 12:11AM $0.006 $0.215 risen by 3,483.33%
$129 Change of Director's Interest Notice 2 Mar 2017 1:02PM $0.007 $0.215 risen by 2,971.43%
$129 Change of Director's Interest Notice 28 Feb 2017 8:20AM $0.007 $0.215 risen by 2,971.43%

651 - 675 of 745 results

Page 27 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.